1-21888152-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005529.7(HSPG2):c.575-86G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.239 in 1,573,620 control chromosomes in the GnomAD database, including 49,129 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 5634 hom., cov: 32)
Exomes 𝑓: 0.24 ( 43495 hom. )
Consequence
HSPG2
NM_005529.7 intron
NM_005529.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.241
Publications
8 publications found
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
- Schwartz-Jampel syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Silverman-Handmaker type dyssegmental dysplasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- Schwartz-Jampel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-21888152-C-A is Benign according to our data. Variant chr1-21888152-C-A is described in ClinVar as Benign. ClinVar VariationId is 1268753.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.57 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HSPG2 | ENST00000374695.8 | c.575-86G>T | intron_variant | Intron 6 of 96 | 1 | NM_005529.7 | ENSP00000363827.3 | |||
| HSPG2 | ENST00000374673.4 | c.380-86G>T | intron_variant | Intron 4 of 6 | 3 | ENSP00000497688.1 | ||||
| HSPG2 | ENST00000412328.5 | n.343-86G>T | intron_variant | Intron 3 of 5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.258 AC: 39169AN: 152004Hom.: 5633 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
39169
AN:
152004
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.237 AC: 336498AN: 1421498Hom.: 43495 AF XY: 0.236 AC XY: 166674AN XY: 707414 show subpopulations
GnomAD4 exome
AF:
AC:
336498
AN:
1421498
Hom.:
AF XY:
AC XY:
166674
AN XY:
707414
show subpopulations
African (AFR)
AF:
AC:
8426
AN:
32776
American (AMR)
AF:
AC:
18265
AN:
43080
Ashkenazi Jewish (ASJ)
AF:
AC:
3411
AN:
25704
East Asian (EAS)
AF:
AC:
21737
AN:
39210
South Asian (SAS)
AF:
AC:
21453
AN:
84676
European-Finnish (FIN)
AF:
AC:
9734
AN:
44300
Middle Eastern (MID)
AF:
AC:
794
AN:
4222
European-Non Finnish (NFE)
AF:
AC:
238187
AN:
1088484
Other (OTH)
AF:
AC:
14491
AN:
59046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
13259
26518
39778
53037
66296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8458
16916
25374
33832
42290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.258 AC: 39191AN: 152122Hom.: 5634 Cov.: 32 AF XY: 0.262 AC XY: 19503AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
39191
AN:
152122
Hom.:
Cov.:
32
AF XY:
AC XY:
19503
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
10854
AN:
41492
American (AMR)
AF:
AC:
5526
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
439
AN:
3472
East Asian (EAS)
AF:
AC:
3033
AN:
5160
South Asian (SAS)
AF:
AC:
1204
AN:
4820
European-Finnish (FIN)
AF:
AC:
2275
AN:
10594
Middle Eastern (MID)
AF:
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15056
AN:
67974
Other (OTH)
AF:
AC:
534
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1442
2884
4327
5769
7211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1295
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.